FY-2023 Top 20 Commercially Successful Inventions
| VACCINES & THERAPEUTICS |
| Rank | | | |
| 1 | SARS Cov-2 Vaccines | Graham, et al. | NIAID |
| 2 | Anti-Coronavirus Antibodies | Mascola, et al. | NIAID |
| 3 | Nutritional Supplement to Treat Macular Degeneration | Ferris, et al. | NEI |
| 5 | CAR T-cell Therapy for Multiple Myeloma | Kochenderfer, et al. | NCI |
| 7 | Pox Virus Based Veterinary Vaccines | Moss, et al. | NIAID |
| 8 | Streptococcus Pneumoniae Vaccines | Beall, et al. | CDC |
| 9 | T Cell Receptor for KRAS G12D Cells and Human Cancers | Yoseph, et al. | NCI |
| 10 | Multivalent Human-Bovine Rotavirus Vaccine | Kapikian, et al. | NIAID |
| 11 | Preconditioning Patients for Adoptive T Cell Therapy | Bot, et al. | NCI |
| 12 | Intranasal Administration of Ketamine to Treat Depression | Zarate, et al. | NIMH |
| 13 | Antibodies, and Fusion Proteins for Treatment of HIV | Dimitrov, et al. | NCI |
| 14 | Adoptive Immunotherapy with Enhanced TIL Cells | Gos, et al. | NCI |
| 18 | Live Attenuated Dengue Tetravalent Vaccines | Whitehead, et al. | NIAID |
| 19 | Prefusion RSV F Proteins for Vaccines | McLeallan, et al. | NIAID |
| | |
| DIAGNOSTICS |
| Rank | | | |
| 4 | HIV-1 Diagnostic Test Kits | Gallo, et al. | NCI |
| 17 | DNA Probe for Breast Cancer Diagnosis (HER-2) | King, et al. | NCI |
| | | | |
| INSTRUMENTATION & DEVICES |
| Rank | | | |
| 16 | Transcranial Magnetic Stimulation System | Zangen, et al. | NIDA |
| | | | |
| RESEARCH MATERIALS & SERVICES |
| Rank | | | |
| 6 | Cell Lines Established from Certain Human Tumors | Oie, et al. | NCI |
| 15 | NIH OVCAR Cell Lines | Hamilton, et al. | NCI |
| 20 | GL-7, GL-1, 11/41 and 1/24 Hybridoma Cell Lines | Hodes, et al. | NCI |
